首页 | 本学科首页   官方微博 | 高级检索  
     


Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy: A Nationwide Cohort Study
Authors:Hyunjean Jung  Pil-Sung Yang  Eunsun Jang  Hee Tae Yu  Tae-Hoon Kim  Jae-Sun Uhm  Jong-Youn Kim  Hui-Nam Pak  Moon-Hyoung Lee  Boyoung Joung  Gregory Y.H. Lip
Affiliation:1. Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea;2. Department of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, South Korea;3. Institute of Cardiovascular Science, University of Birmingham, England;4. Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, England;5. Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Abstract:
Keywords:atrial fibrillation  hypertrophic cardiomyopathy  non-vitamin K antagonist oral anticoagulants  ischemic stroke  AF  atrial fibrillation  congestive heart failure, hypertension, age ≥ 75  diabetes, stroke, vascular disease, age between 65 and 74, and female  HCM  hypertrophic cardiomyopathy  HR  hazard ratio  ICD-10  International Classification of Disease, 10th Revision  MI  myocardial infarction  NOAC  non-vitamin K antagonist oral anticoagulant  OAC  oral anticoagulant  PS  propensity score  TTR  time in therapeutic range
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号